Publications by authors named "Nick Van Es"

Claim this Profile
M
Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study.
Vincent R Lanting, Floris T M Bosch, Emily S L Martens, Pieter W Kamphuisen, Stefano Barco, Francesca Schieppati, Luis Jara-Palomares, Nick van Es

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis.
Kristina Vrotniakaite-Bajerciene, Ranjeeta Mallick, Toshihiko Takada, Noemie Kraaijpoel, Maarten van Smeden, Nick van Es

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trial.
Nick van Es, Luuk J J Scheres, Kristen M Sanfilippo, Harry Büller, Marc Carrier, Renato D Lopes

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin generation profiling in rare coagulation factor deficiencies: associations with bleeding severity and potential for screening.
Bauke Haisma, Sanna R Rijpma, Marjon H Cnossen, Paul L den Exter, Ilmar C Kruis, Nick van Es, Joline L Saes

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune checkpoint inhibitor avelumab increases aortic inflammation on [18F]FDG PET/CT: A retrospective cohort study.
Anniek Strijdhorst, Reindert F Oostveen, Mark P A Schilder, Arthur J A T Braat, Youssef Chahid, Erik S G Stroes, Margot Tesselaar, Nick van Es

PLoS One· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide 1 receptor agonists and venous thromboembolism: putting the evidence on the scale.
Judith P L Verlaan, Nick van Es, Luuk J J Scheres

J Thromb Haemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of catheter related thrombosis: A systematic review, meta-analysis, and national survey.
Laurens A Oomen, Janette van Diest, Felice R M Lucas, Jitske Rijpkema, George L Burchell, Nick van Es

J Vasc Surg Venous Lymphat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis and retrospective study.
Harish Eswaran, Rohan R Kasthuri, Pavan K Bendapudi, Alok A Khorana, Raj S Kasthuri, Nick van Es

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in patients with chronic lung disease: an individual-patient data meta-analysis.
Vicky Mai, Toshihiko Takada, Noemie Kraaijpoel, Nick van Es, Ranjeeta Mallick

J Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke severity and other predictors of venous thromboembolism in stroke patients-a population-based cohort study.
Ditte Vestergaard Hansen, Nick van Es, Henrik Toft Sørensen, Jonathan M Coutinho, Nils Skajaa

Res Pract Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study.
Florian Moik, Erzsébet Horváth-Puhó, Cihan Ay, Ingrid Pabinger, Frits Mulder, Nick van Es

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy and Mortality Risk in Older Adults with Hip Fractures.
Karin Vleeshouwers, Janneke J C Bastings, Renée Brüggemann, Melanie J de Jong, Mark van den Boogaart, Nick van Es

J Am Med Dir Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Cancer in the Short and Long Term after Incident Venous Thromboembolism: The HUNT and Tromsø Studies.
Camilla Langholm, Nikolai Hagensen Eide, Kristian Hveem, Nick van Es, Sigrid K Brækkan

Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.
Samuel D Curtis, Tingshan Liu, Yuxin Bai, Yuxuan Wang, Sambit Panda, Nick van Es

Proc Natl Acad Sci U S A· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of computed tomography venography compared with ultrasonography for detection of peripherally inserted central venous catheter-related thrombosis in patients with cancer: the DETECT study.
Noori A M Guman, Bart M van Dooremaal, Ludo F Beenen, Maeke J Scheerder, Anne-Marie Becking, Nick van Es

J Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study.
Noori A M Guman, Noémie Kraaijpoel, Frits I Mulder, Marc Carrier, Luis Jara-Palomares, Jan Beyer-Westendorf, Johannes M M B Otten, Nick van Es

Res Pract Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study.
Vincent R Lanting, Kika van Bergen En Henegouwen, Floris T M Bosch, Michael A Grosso, Annelise Segers, Nick van Es

J Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study.
Sterre P E Willems, Marjon H Cnossen, Nick van Es, Paul L den Exter, Ilmar C Kruis, Joline L Saes

Res Pract Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study.
Sterre P E Willems, Marjon H Cnossen, Nick van Es, Paul L den Exter, Ilmar C Kruis, Joline L Saes

J Thromb Haemost· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies.
Anniek Strijdhorst, Winnie G Vos, Laura A Bosmans, Kim E Dzobo, Pascal J H Kusters, Esther Lutgens, Nick van Es

Atherosclerosis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study: Reply.
Vincent Lanting, Emese Vágó, Erzsébet Horváth-Puhó, Frits Mulder, Nick van Es

J Thromb Haemost· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour-Derived Extracellular Vesicles.
Agustin Enciso-Martinez, Caroline Løppke, Joyce J Koene, Jade Ebbelaar, Meike van der Geest, Nick van Es

J Extracell Vesicles· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort Study.
Frits I Mulder, Erzsébet Horváth-Puhó, Nick van Es, Lars Pedersen, Harry R Büller

JACC CardioOncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis.
Faizan Khan, Tobias Tritschler, Caterina E Marx, Vincent Lanting, Bram Rochwerg, Jessalyn Holodinsky, Kirsten Fiest, Nick van Es

Eur Heart J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study.
Bauke Haisma, Sanna R Rijpma, Marjon H Cnossen, Paul L den Exter, Ilmar C Kruis, Nick van Es, Joline L Saes

Thromb Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis